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ABSTRACT

Kadel, Saurav. M.S.R.C.E., Department of Mechanical and Materials Engineering,
Wright State University, 2020. Computational Assessment of Aortic Valve Function and
Mechanics under Hypertension

Calcific aortic valve disease (CAVD), the most common valvular heart disorder, is
associated with complications such as stroke, heart attack, aortic aneurysm, left ventricular
hypertrophy, and ultimately death. While hypertension has been identified as a major risk
factor for CAVD, the mechanisms by which it may promote calcification are still unknown.
Given the sensitivity of valvular tissue to mechanical stress alterations, the hemodynamic
abnormalities linked to hypertension may play a role in the development of CAVD.
Further, the effects of hypertension on the left ventricular functionality and coronary flow
resistance remain largely uninvestigated. Hence, the objectives of this thesis were 1.) to
quantify computationally AV hemodynamics and regional leaflet mechanical stresses
under normotensive, prehypertensive and stage-1 hypertensive conditions using FluidStructure interaction modeling, and 2.) characterize the effect of hypertensive conditions
on ventricular workload and coronary flow resistance. This study will provide insights on
the mechano-etiology of CAVD in hypertensive patients as well as the ventricular
functionality and coronary flow under hypertension.
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CHAPTER 1:
INTRODUCTION
The human circulatory system consists of the heart, the heart valves which ensure
unidirectional blood flow, the system of blood vessels, and the circulating blood, which act
in harmony to control blood flow to the various tissues and organs.
1.1 Heart Anatomy and Physiology
The heart is the primary organ of the cardiovascular system and is crucial for blood
circulation. It can be separated sagitally into left and right sides by a large muscular wall
known as the interventricular septum (Figure 1 [1]). Each side can further be segregated
into two superior and inferior chambers known as the atria and ventricles, respectively. The
left side of the heart is responsible for systemic circulation whereas the right side is
responsible for the pulmonary circulation. Briefly, pulmonary circulation is defined as the
route traveled by blood from the various tissues and organs to the right side of the heart,
where it is pumped to the lungs for oxygenation and gas exchange. The systemic circulation
encompasses the route of the freshly oxygenated blood from the lungs to the left side of
the heart, where it is subsequently pumped to the rest of the body.
Unidirectional blood flow in the heart is maintained throughout the cardiac cycle
with the help of four distinct heart valves: the atrioventricular valves (left: mitral valve,
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right: tricuspid valve) located at the junction between each chamber, and the semilunar
valves (left: aortic valve, AV, right: pulmonary valve) located at the junction between each
ventricle and corresponding artery.

Figure 1: Heart anatomy [1]
The cardiac cycle is divided into two phases: diastole and systole. During the diastolic
phase, blood from different parts of the body returns to the heart and flows into the right
atrium increasing the pressure in the right atrium (Figure 2a [2]). The tricuspid valve opens
when this pressure exceeds the right ventricular pressure, allowing blood to flow passively
into the right ventricle. Simultaneously, oxygenated blood returning from the lungs fills
the left atrium, which then flows into the left ventricle through the mitral valve due to an
increase in left atrial pressure. During systole (Figure 2b [2]), the atrial contraction forces
the remaining blood from the two atria to flow into their ventricles. This is followed by a
phase of isovolumetric contraction in which the ventricles contract, but the ventricular
pressure does not exceed the aortic pressure forcing the semilunar valves and the
atrioventricular valves to remain closed. When the ventricular pressure exceeds the aortic
2

pressure, the semilunar valves open and blood flows into the aorta and then to the rest of
the body. The heart muscle relaxes by the end of systole and the diastolic phase begins
again.

Figure 2: Schematic showing heart valve function during systole (a) and diastole (b) [2]

1.2 Left Ventricle Anatomy and Physiology
Located at the bottom left of the heart, the left ventricle (LV) is the largest heart
chamber. It contracts and expands to eject blood into the aorta. The LV consists of thick
muscular walls, which aids in the high-pressure systolic ejection.
In the systemic circulation, the LV contraction increases the pressure within the
ventricle from 0 mmHg to a peak-systolic pressure of about 120 mmHg, overcoming the
arterial resistance. This allows for oxygenated blood to flow into the aorta and then to the
rest of the body. LV function is measured by cardiac output (CO), which quantifies the
amount of blood pumped per minute and is calculated as the product of the stroke volume
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and the heart rate. An adult human body typically has a CO of 5.0 L/min, stroke volume of
70 ml, and a heart rate of 70 beats per minute for a cardiac cycle of 0.86 seconds [3].
1.3 Aortic Valve Anatomy and Physiology
The aortic valve (AV), situated between the LV and the aorta, allows for
unidirectional blood flow from the heart throughout the systemic circulation. The valvular
opening and closing mechanism are facilitated by the transvalvular pressure gradient
(TPG), which is the pressure difference between the LV and the aorta. During diastole, the
aortic and left ventricular pressure (80 and 0 mmHg, respectively) result in a negative TPG,
which closes the valve. The valve opens due to the positive TPG resulting from the
increased LV pressure (up to 120 mmHg) and aortic pressure (80 to 120 mmHg) during
systolic contraction.
The AV features three semilunar leaflets housed in a region known as the aortic
root at the base of the aorta (Figure 3a [4]). Three hemispherical cavities, known as the
sinus of Valsalva, asymmetrically protrude from the root. Two of these sinuses house the

Figure 3: Aortic valve anatomy (a) [4] and unfolded valve showing the leaflets and
the sinuses (b) [5]
4

coronary ostia, which are the openings that connect the sinuses to their respective coronary
artery (left coronary artery, right coronary artery) (Figure 3b [5]). The leaflets and the
sinuses are named based on their proximity to the ostia and are known as the left-coronary,
right-coronary and non-coronary leaflet/sinus.
AV leaflets consist of different regions (Figure 4a [6]). The topmost margin of the
leaflet is called the free edge. The region where the free edge and the aorta meet are called
the commissures. The coaptation zone is the upper region of the leaflet just below the free
edge, which provides a contact region between the three leaflets during valve closure. The
bottom portion is called the belly, which consists of the attachment edge that connects the
leaflet to the sinus. The leaflet thickness varies spatially across those regions and is also
dependent on the leaflet. Histologically, AV leaflets feature a tri-layered structure, which
consists of the fibrosa, the ventricularis, and the spongiosa. The fibrosa faces the aorta side
and consists of circumferentially oriented collagen fibers, valve interstitial cells (VICs),
valve endothelial cells (VECs), and elastin fibers (Figure 4b [7]). The collagen fibers
provide strength to the leaflets whereas the elastin fibers contribute to the flexibility and
reduce radial strain. VICs maintain the valvular structural integrity. VECs are the outer
lining of the AV leaflets that protect from cell infiltration and lipid accumulation. VECs
play an important role in valvular homeostasis as they respond to strain and wall shear
stress (WSS) by changing their morphology, functions, and gene and protein expression
[8], [9]. The ventricularis faces the LV and is predominantly comprised of VICs, VECs,
and radially oriented elastin fibers, which helps the valve endure bending motion over the
cardiac cycle. The spongiosa, located between the fibrosa and the ventricularis, mainly
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consists of glycosaminoglycans (GAGs), which provide lubrication and cushioning effect
to dampen the compressive forces on the leaflets.

Figure 4: Sectional view of a leaflet showing different regions (a) [6] and
cellular architecture of the aortic valve (b): A) VECs, B) VICs, C) collagen, D)
GAGs, E) Elastin [7]
1.4 Coronary Flow
Originating from the coronary ostias, the two coronary arteries are responsible for
supplying oxygenated blood to the heart muscles. The left coronary artery (LCA) and the

Figure 5: Schematic of coronary arteries [10]
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right coronary artery (RCA) supplies blood to the left ventricular wall and right ventricular
wall, respectively, as well as the interventricular septum (Figure 5 [10]).
Coronary perfusion pressure (CPP), which is the difference between the diastolic
aortic pressure and end-diastolic left ventricular pressure [11] and coronary resistance drive
the coronary flow [12], [13]. During systole, the myocardial contraction causes a collapse
of the coronary arteries, which leads to a reduction of coronary blood flow. During diastole,
the heart muscle relaxes, which causes maximum coronary blood flow. Arteries are
generally able to maintain constant blood flow to the organs across a wide range of driving
pressure through a process known as autoregulation [14]-[15]. Changes in the arterial
resistance, which are achieved by changes in arterial diameter (remodeling) and blood
viscosity, are considered the primary mechanism behind autoregulation. As compared to
other components of the vasculature, the coronary arteries exhibit an advanced
autoregulatory capacity [16], which results in the maintenance of a relatively constant
blood flow despite changes in CPP. Coronary flow remains unaffected for CPP ranging
from 60 to 130 mmHg [17] and mean arterial pressure ranging from 60 to 140 mmHg [18].
Coronary flow becomes pressure-dependent outside this range.
Coronary flow plays a crucial role in AV hemodynamics. The presence of sinus
vortices and their role in aiding leaflet closure have been well documented in many studies
[19], [20]. To better understand this, an experimental study was carried out on the AV to
demonstrate the impact of coronary flow on sinus hemodynamics and AV leaflet
mechanics [21]. The study not only showed that the coronary flow generated complex
vortex dynamics and increased velocity close to the base of leaflet, but also resulted in a
larger valve opening area and increased WSS in the leaflet base, which was not observed
7

in the non-coronary sinus. Another computational study showed that the presence of
coronary circulation led to the suppression of vortices in the coronary sinuses, which
subsequently generated alterations in leaflet WSS environment [22].
1.5 Calcific Aortic Valve Disease
Calcific aortic valve disease (CAVD), or the formation of calcific nodules on the
AV leaflets, is the most common AV disease and the third most common heart disease.
CAVD is a slow progressive disorder that is characterized with mild valvular leaflet
thickening at the beginning, known as aortic sclerosis. Aortic sclerosis affects about 25%
of the geriatric population [23]. As the disease progresses, the thickened leaflets undergo
calcification on the fibrosa, leading to aortic stenosis (AS), overtime (Figure 6 [24]). AS
causes substantial reduction in the orifice area and valve functionality. It is prevalent in
0.4% of the general population and 1.7% of the geriatric population [25]. AS is associated
with high mortality rates: up to 50% in the first two years after symptoms appear [26], [27].
The symptoms of CAVD are fatigue, shortness of breath, fainting, chest pain and heart
murmur. Left untreated, the disease eventually leads to the narrowing of the valve orifice,
obstruction in blood flow, coronary heart disease, and death [28]. Traditional risk factors

Figure 6: CAVD progression from healthy to sclerosis and stenosis [24]
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of CAVD are age, cigarette smoking, male sex, hypertension, increased lipoprotein and
diabetes mellitus [7].
CAVD pathogenesis can be divided into three stages: inflammation, fibrosis and
calcification [29]–[32]. The inflammatory stage is characterized by cellular infiltration,
lipids accumulation and expression of pro-inflammatory cytokines such as transforming
growth factor beta-1 (TGF-ß1) and bone morphogenic proteins (BMPs). In the fibrotic
stage, the fibroblast-like phenotype differentiates into myofibroblast- or osteoblast-like
phenotype. Also, the loss of balance between matrix metalloproteinases (MMPs) and the
tissue inhibitors of matrix metalloproteinases (TIMPs), causes the disorganized
extracellular matrix (ECM) fibers to accumulate and lead to leaflet thickening. Lastly, in
the calcification stage, cytokines released by the osteoblasts-like VICs activate pro-calcific
pathways leading to calcific lesion formation on the fibrosa.
The severity of CAVD is measured by the effective orifice area (EOA), the orifice
jet velocity and the mean TPG (Table 1) [33]. The EOA is the minimum cross-sectional
area of the jet downstream of the valve orifice. In a healthy AV under normal conditions,
the EOA has been reported to be in the range of 3-5 cm 2 [34].
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Table 1: Classification of CAVD severity

AV jet velocity (m/s)

Mean TPG (mmHg) EOA (cm2)

Aortic sclerosis

< 2.5

< 10

3-4

Mild AS

2.5 – 3

10-20

1.5-3.0

Moderate AS

3-4

20-40

1.0-1.5

Severe AS

>4

> 40

< 1.0

1.6 Treatment for CAVD
The most common treatment of CAVD involves the replacement of the AV.
Prosthetic valves such as bileaflet mechanical valves and bioprosthetic valves have been
used for AV replacement. Bileaflet mechanical valves consist of two semilunar disks
hinged to a fixed valvular ring, which makes them very durable (Figure 7a) [35]. However,
patients with mechanical valves are required to take lifelong anticoagulation medication to
avoid the formation of blood clots due to the thrombogenic leaflet material used [36].
Bioprosthetic valves, on the other hand, consist of porcine or bovine AV leaflets mounted
on a polymeric or metallic stent (Figure 7b). These bioprosthetic valves do not require
anticoagulation medication, but interventions are required every 10-15 years due to their
limited durability and lifespan [37], [35]. Although AV replacements with prosthetic valves
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are effective, they require open heart surgery, which is not ideal for elderly and inoperable
patients. To address that need, a noninvasive transcatheter aortic valve replacement
(TAVR) was introduced in 2002. TAVR utilizes a valve made of animal tissue folded in
an expandable stent, which is carried by a catheter through the femoral artery and guided
to the AV. The new implant is stationed, and the stent is expanded inside the diseased valve
(Figure 7c). TAVR has a high success rate and has been used in more than 80,000 cases
[38], but some patients have been diagnosed with complications like stroke, coronary
obstruction, valvular leakage, hypotension, renal injury and necessity of pacemaker after
treatment [39], [40], [41]. Although TAVR has a lower mortality rate than standard valve
prostheses, over 25% of post-TAVR patients either do not recover their normal way of life
or die [42].

Figure 7: Bileaflet mechanical valve (a), stented porcine bioprosthetic valve (b),
bioprosthetic expanded over a balloon (TAVR) (c) [35]
1.7 Hypertension
Hypertension is a common risk factor of CAVD with over 60% of hypertensive
patients developing CAVD [43]. Hypertension affects 26% of the global population [44]
and over 45% of the adult population in the United States [43]. At rest, for most adults,
normal arterial blood pressure (BP) varies between 120 mmHg during systole and 80
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mmHg during diastole. Hypertension, or high blood pressure, is defined as the persistent
increase in the systolic/diastolic BP from normal BP. Hypertension is classified into two
stages (Table 2) with blood pressure greater or equal to 130/80 mmHg (systolic/diastolic)
considered hypertensive [45].
Table 2: Stages of blood pressure
Systolic pressure

Diastolic pressure

(mmHg)

(mmHg)

Normal

≤ 120

≤ 80

Elevated or prehypertension

120-129

≤ 80

Hypertension stage-1

130-139

80-89

Hypertension stage-2

140 or higher

90 or higher

Stages of blood pressure

Primary hypertension, which affects 90-95% of hypertensive patients, has no
identifiable cause. Secondary hypertension, which affects the remaining 5-10% of
hypertensive patients, is linked to renal disease, endocrine disorders, or other identifiable
causes [46]. In both hypertension types, the actual increase in blood pressure is associated
with either an increase in systemic vascular resistance (SVR) or an increase in CO [47].
Chronic hypertension is mostly associated with an increase in SVR rather than CO. The
increased SVR is caused by an increase in wall thickness of the blood vessels and by a
decrease in vessel diameter. Increased sodium retention in the blood due to renal disorders,
higher sympathetic activity and increase in angiotensin II levels have been shown to
increase the CO and SVR [48], [49]. The common risk factors of hypertension are age,
race, obesity, smoking, alcohol, stress and chronic conditions such as kidney disease,
12

diabetes and sleep apnea. Hypertension leads to a host of diseases like heart attack, stroke,
aneurysm, chronic kidney disease, vision loss and dementia in the long run [50]. Most
people diagnosed with hypertension are treated with antihypertensive medications in
addition to lifestyle modification.
1.8 Left Ventricular Hypertrophy
Left ventricular hypertrophy (LVH) is the increase in the muscular mass of the LV
due to the thickening of the wall muscles. LV needs to pump blood regularly irrespective
of different heart conditions like hypertension and AS. LVH is prevalent in 17-67% of
patients with CAVD [51] and 36-41% of hypertensive patients [52]. The narrowing of the
valve opening and obstruction of blood flow due to AS or the elevated aortic pressure under
hypertension [53], [54], forces the LV to pump harder. To compensate for the increased
workload, the muscular LV wall thickens and, in the process, alters the LV geometry. This
mechanism helps in maintaining a physiologic CO. Left untreated, the thickened muscles
ultimately lose their elasticity and may fail to maintain the CO leading to heart attack and
stroke. LVH caused by AS might require AV repair or replacement. In hypertensive case,
medication is the preferred treatment.

1.9 Etiologies of CAVD
Genetic factors have been the most common etiology of CAVD. Genetic mutations
of the transcriptional factor NOTCH1 [55]–[57], which controls the process of osteogenic
differentiation, has been extensively studied under the genetic theory behind CAVD. Gene
coding for the vitamin D receptor [58] and lipoproteins synthesis [59] have also been
identified in patients with CAVD.
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Although CAVD has been historically linked to a genetic origin, an alternate
hemodynamic theory has emerged. The hemodynamic theory (Figure 8) proposes that risk
factors such as age, hypertension and bicuspid aortic valve (BAV) could produce
hemodynamic stress abnormalities on the AV leaflets. VECs can sense the altered stresses
and then transduce them into various biological responses that might lead eventually to
leaflet calcification. Calcification can then increase the degree of hemodynamic
abnormality on the leaflets, which may contribute to disease progression.

Figure 8: Hemodynamic theory of CAVD

1.9.1. Support for the Hemodynamic Theory
WSS is the frictional viscous stress acting on the wall due to the spatial gradient of
blood flow velocity. Physiologic WSS levels have been shown to play an important role in
the maintenance of valvular homeostasis [60], [61], while WSS alterations have been
shown to trigger a pathological response in the AV leaflets [62]. An ex vivo study in
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porcine AV leaflets showed that the fibrosa responded to non-physiological pulsatile WSS
by an increase in the pro-inflammatory cytokines (TGF-β1 and BMP-4) expression,
whereas exposure of the ventricularis to non-physiologic oscillatory WSS did not trigger
any response [63]. Another ex-vivo study examined the influence of altered WSS
magnitude and frequency on porcine AV leaflet tissue [64]. The study revealed an increase
in BMP-4 and TGF-β1 expression under elevated WSS levels and an increase in ECM
degradation under sub-/supra-physiologic WSS frequency (Figure 9), effectively
demonstrating the sensitivity of AV leaflets to abnormal WSS.

Figure 9: Pro-inflammatory state index (a) and remodeling state index (b) [64]
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1.10 Flow Characterization in the Aortic Valve and Coronary Arteries
AV and coronary flows have been widely assessed in-vivo using magnetic
resonance imaging (MRI) and echocardiography [65]–[68]. One MRI study showed the
presence of vortices in the individual sinuses of the AV after peak systole, which persisted
until diastole [69]. Similar techniques have been used for assessing the impact of increased
arterial stiffness on coronary perfusion [70], [71]. In vitro studies have used various optical
techniques to assess AV flow characteristics and WSS calculation in native and prosthetic
valves. Laser doppler velocimetry (LDV) studies in mechanical valves showed the
presence of high WSS on the ventricular leaflet surface subjected to pulsatile flow, and low
WSS on the leaflet surface facing the aorta [72], [73]. Particle image velocimetry (PIV)
measurements have also been carried out to characterize differences in sinus
hemodynamics in different valve morphologies in terms of fluid shear stress and vorticity
dynamics [74]. The study revealed the slow formation of vortices and the existence of
higher shear stresses in the congenital BAV relative to the normal tricuspid aortic valve.
The opening and closing mechanisms of the AV have also been investigated using PIV.
One study subjected AV with different flow profiles by simply changing the duration of
peak systole. Results showed that early peak systole, normally found in healthy individuals,
instigated efficient valvular function when compared to late peak systole [75]. Clinical and
experimental studies have been widely reported in the literature for the assessment of AV
and coronary hemodynamics under normal blood pressure. However, there exists a lack of
in-vivo and in-vitro data characterizing the flow in the AV under hypertension.
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1.11 Computational Modeling of the Aortic Valve and Coronary Circulation
In addition to medical imaging and in-vitro measurements, an alternative
computational modeling method has been used to effectively characterize the
hemodynamic environment of the AV and the coronary arteries. This approach also
addresses the limitations of spatial and temporal resolution and data insufficiency, which
is common in clinical and experimental techniques.
1.11.1 Finite Element Method
The finite element method (FEM) is a computational tool used to solve problems
in solid-state mechanics. The basic concept of FEM is to divide the structural domain into
discrete elements and solving the governing equation for each element. The global solution
for the structure is obtained by combining the discrete solutions obtained from these
elements. FEM studies of the AV have mostly looked at leaflet deformation and structural
stresses developed in the leaflets [76]–[79]. One such study found that the non-coronary
leaflet experienced the highest stresses of all three leaflets and that the maximum stresses
were concentrated near the coaptation region [80]. FEM studies have also highlighted the
importance of the sinus and valve geometry in reducing leaflet stress and strain distribution
[81] and the role of aortic root compliance on valve opening [82], [83]. While FEM studies
are essential in structural analysis, they do not account for blood flow and are therefore not
suitable for the assessment of leaflet WSS.
1.11.2 Computational Fluid Dynamics Modeling
Computational fluid dynamics (CFD) is a modeling technique that solves problems
involving fluid mechanics. CFD predominantly uses the finite volume method (FVM) for
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discretization. In FVM, the fluid domain is first discretized into several control volumes or
cells. The Navier-Stokes equations are approximated on each of the cells using a cell center
scheme. The physical quantities (e.g., velocity, pressure) are then computed on the node of
each cell. Using cell centered interpolation profiles, these physical quantities are then
derived for the whole fluid domain. CFD studies on the AV subjected to physiologic
transvalvular pressure have investigated leaflet stresses during systole and have found
regions of high stresses at the base of the leaflets [84]. CFD AV models have been mostly
used to assess the velocity profiles, flow patterns, flow helicity and WSS characteristics on
different AV morphologies and mechanical valves under normal blood pressure [85]–[88].
CFD studies have provided important information about AV flow features but neglect the
interaction between the blood flow and the leaflets, which is a major drawback.
1.11.3 Fluid-Structure Interaction Modeling
Fluid-structure interaction (FSI) modeling is a computational technique modeling
the interaction between a moving structure and a surrounding fluid flow. FSI modeling
accounts for the transfer of momentum between a structure and a fluid, and therefore has
been widely used to investigate valvular hemodynamics. FSI models can be developed
using fixed-grid and moving-grid methods. In the fixed-grid method, separate grids are
used for the discretization of the fluid and the structural domain. The fluid grid is fixed but
the structural grid is free to move inside the fluid domain. Immersed boundary (IB) and
fictitious domain (FD) methods are two implementations of the fixed-grid method. In the
IB method, body force sources are introduced into the governing equations to account for
the influence of the boundary. In the FD method, Lagrangian multipliers are used to couple
the fluid and structural domains along the fluid-structure interface . Fixed grid methods
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have been used to simulate AV hemodynamics [89]–[91]. However, in these methods, the
grid does not fall automatically on the interface. Therefore, the precise location of the
interface is approximated, which prevents accurate characterization of the leaflet WSS.
The ALE method addresses those limitations by implementing a moving fluid mesh
fitted to the moving boundary (Figure 10) [92]. While this method accurately tracks the
location of the fluid-structure interface, large structural deformations may result in the
degradation of the fluid mesh quality and the creation of negative cell volumes, which can
result in convergence issues. Remeshing techniques can be utilized to prevent this issue by
locally remeshing the cells in the fluid domain.

Figure 10: Fluid mesh in fixed grid method (a) and ALE method (b) [92]

Two-dimensional (2D) [93], [94] and three-dimensional (3D) AV models [92],
[95]–[97] have been used to simulate the native AV hemodynamics. FSI studies have also
been used to investigate the valvular dynamics, the impact on the structural stress state [98]
as well as the impact of nonlinear leaflet material [99] and AV asymmetry on the leaflet
stress distribution [100]. A 3D FSI model previously developed in our laboratory
characterized the global and regional WSS in AV leaflets [101]. The study reported a

19

surface-averaged leaflet WSS magnitude ranging from 5.8 to 19.9 dyn/cm 2 on the fibrosa
over a cardiac cycle. Another FSI study investigated the impact of coronary flow on AV
hemodynamics and found that coronary flow caused an asymmetry in the sinus
hemodynamics during diastole. Intense vortices were observed in the non-coronary sinus
in comparison to the moderate vortices observed in the coronary sinuses. Results also
showed up to 30% increase in time-averaged WSS (vs. no coronary flow model) on the
fibrosa, demonstrating the crucial role played by the coronary circulation in AV
hemodynamics [22].
1.12 Rationale for the Thesis
Studies have demonstrated the crucial role played by WSS in valvular function and
disease [64]. The increased expression of pro-inflammatory biomarkers reported under
altered stress conditions has strongly highlighted the influence of abnormal hemodynamics
in AV disease. Other studies aimed at characterizing hemodynamic stress alterations in
structurally abnormal valves such as the BAV have revealed the existence of hemodynamic
stress abnormalities on the leaflets as compared to the normal AV [101]–[103]. These
studies have provided compelling evidence in support of the hemodynamic theory of
CAVD.
Hypertension is another important risk factor of CAVD. Studies have demonstrated
the association between hypertension and CAVD, and have reported high level of incidence
of hypertension in CAVD patients and vice versa [104]–[108]. A recent epidemiological
study has reported that over 60% of hypertensive patients developed sclerosis and about
5% developed AS [109], [43]. However, the mechanism by which hypertension may
promote CAVD is still under debate. Numerous studies have suggested the existence of
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abnormal AV hemodynamics under hypertension [110]–[114]. Other studies that have
looked at the effects of mechanical forces ( stretch, pressure, and fluid shear stress) on the
remodeling activity of the valve have also suggested the existence of an abnormal
hemodynamic environment under elevated pressure conditions [115]–[117]. An in-vitro
study revealed that hypertensive conditions increased stretch magnitude on AV leaflets,
which could in turn translate to leaflet dynamics and AV hemodynamic abnormalities
[118]. Overall, these epidemiological and experimental studies suggest that hypertension
may lead to altered AV hemodynamics, and ultimately CAVD pathogenesis. However, the
AV hemodynamic environment under hypertensive conditions remains largely unknown.
Studies characterizing AV hemodynamics and leaflet WSS under normal blood pressure
are abundant in the literature but are almost nonexistent for hypertension. Hence, the
objective of the present study is to investigate the impact of hypertension on valvular
hemodynamics. The results of this mechanical investigation could be used in the future to
test the validity of the hemodynamic theory of CAVD due to hypertension.
To address this objective, the accurate assessments of the valvular flow
characteristics and leaflet WSS environment are required. Medical imaging techniques
have been used to measure the flow through the AV but are hampered by low spatial and
temporal resolutions [119], [120]. In-vitro measurement techniques such as LDV and PIV
have generated important data on leaflet WSS. However, LDV can only measure the three
velocity components at a point in the flow field [121], [122]. Similarly, PIV can only
capture the two velocity components in one flow section [123], [124]. Therefore, LDV and
PIV are not suitable for the estimation of the spatial velocity gradients, and the assessment
of the leaflet WSS distributions in a 3D flow environment.
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Computational modeling techniques such as FEM and CFD have been used in AV
studies but are constrained to structural and fluid flow analysis, respectively, and are unable
to account for the momentum transfer between the moving structure and the blood flow
when used in isolation. FSI modeling overcomes this limitation and can provide accurate
estimation of leaflet WSS as shown in previous studies.
In addition to the potential impact of hypertension on AV flow, studies have also
associated hypertension with altered ventricular function and increased ventricular work
[54], [125], [126]. However, no quantitative data has been published on the impact of
hypertension on LV overload. Similarly, the effects of hypertension on coronary flow have
not been quantified. Therefore, this study aims at providing important information on the
impact of hypertension on AV hemodynamics, left ventricular work and coronary flow
using a FSI modeling approach.
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CHAPTER 2:
SPECIFIC AIMS
Hypertension is a common risk factor for CAVD but the mechanisms by which elevated
pressure contributes to valvular pathogenesis remain largely unknown. The main
hypothesis of this study is that hypertension generates flow alterations in the AV and WSS
abnormalities on the valve leaflets, which may trigger CAVD pathogenesis. In addition,
hypertension is also known to affect ventricular function and coronary flow, but the
impacts of elevated blood pressure on ventricular mechanics and coronary flow regulation
have not been elucidated. Hence, the focus of this study is to address the following research
questions: Does hypertension affect the hemodynamic stress environment on the AV leaflets
and, if so, to what extent? What is the impact of hypertension on coronary flow and the
maintenance of myocardial perfusion? What is the impact of hypertension on leftventricular function?
Therefore, the main objective of this study is to quantify computationally AV
hemodynamics, coronary flow resistance and ventricular performance under
normotensive and hypertensive conditions. Three specific aims are developed to fulfill
this objective:
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Specific aim 1: To develop and validate a computational model for characterizing
valvular flow under normotensive condition
In this aim, a FSI model featuring a realistic AV and aortic root, and including the coronary
arteries was designed to simulate valvular flow under normotensive condition. A
previously validated coronary-AV geometry was improved to achieve realistic valvular
motion and to ensure computational stability. Boundary conditions representing
physiologic cardiac output, blood pressure and coronary perfusion were applied to the
model. A FSI modeling strategy based on the ALE method was adopted to account for the
interactions between the moving leaflets and blood flow, and for mesh motion. The blood
and the leaflets were modeled using a Newtonian incompressible fluid and a hyperelastic
Mooney-Rivlin material formulation, respectively. The model was validated by comparing
the predicted flow field, leaflet dynamics and WSS characteristics with previously
published clinical, experimental and computational data.
Specific aim 2: To quantify AV hemodynamics and leaflet dynamics under
hypertensive conditions
The main focus of this aim was to characterize AV hemodynamics under prehypertensive
and stage-1 hypertensive conditions and to compare it with the predictions obtained in the
normotensive model of Aim 1. The computational framework developed in Aim 1 was
modified to incorporate prehypertensive and stage-1 hypertensive boundary conditions.
The same physiologic coronary flow as that implemented in the normotensive model was
maintained in these models to account for coronary remodeling and the maintenance of
myocardial perfusion. The flow structure, leaflet WSS characteristics and leaflet dynamics
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were compared to those predicted in the normotensive model to elucidate the impact of the
degree of hypertension on AV function and mechanics.
Specific aim 3: To investigate the effects of hypertension on coronary resistance and
LV workload
The objectives of this aim were to explore the cause-and-effect relationships between
hypertension and 1) coronary remodeling as quantified by alterations in coronary
resistance, and 2) ventricular hypertrophy as quantified by increased ventricular workload.
To quantify the effects of hypertension on coronary flow resistance, the models from Aim
1 and Aim 2 were revisited and flow resistance in the coronary arteries was evaluated under
normotensive, prehypertension and hypertension conditions. To assess the effects of
hypertension on LV workload, the models were further analyzed to obtain the LV pressurevolume curves and quantify the work done by the LV under normotensive, prehypertensive
and stage-1 hypertensive conditions.
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CHAPTER 3:
SPECIFIC AIM 1: To develop and validate a computational model for characterizing
valvular flow under normotensive condition
The focus of this aim was to design the coronary-AV model, and to establish appropriate
modeling strategy and methodology to simulate valvular flow under normotensive
conditions. The predicted AV hemodynamic and leaflet mechanical characteristics were
also compared with those found in the literature for validation purpose. The methodology
included the reconstruction of the valve geometry, the generation of the mesh, the
formulation of the material model, the numerical formulation of the FSI problem, and the
development and prescription of appropriate boundary conditions for the normotensive
case. AV hemodynamics was assessed in terms of flow characteristics, leaflet WSS and
stretch ratios.
3.1. Methodology
3.1.1. Previous Coronary-AV model
A coronary-AV model previously designed in our laboratory was taken as
a foundation for the development of the improved model used in this thesis. This
section describes the previously published model.
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3.1.1.1. Valve Geometry
The valve geometry consisted of three identical leaflets housed in the aortic root, and
the two coronary arteries with extended inlet and outlets [101]. The leaflets, the aortic
sinuses and the coronary arteries were constructed using published human AV dimensions
consisting of the diameters for the aortic and ventricular section, the aortic wall thickness,
the sinus height and diameter, and the height of the leaflets from the aortic annulus (Table
3) [98], [127]. The spatial variation of the leaflet thickness from the base to the tip was also
incorporated in the geometrical model (Table 4) [80]. Different geometric guides such as
the tip point, leaflet centerline, commissure point and annulus point were created based on
the above dimensions (Figure 11a [128]). The aortic wall and the leaflets were designed in
SolidWorks using these guides. Surface features were utilized to first generate one half of
the aortic root and a leaflet, and a full AV geometry with all three leaflets and the full aortic
root was then obtained by using the mirror function (Figure 11b). The coapted leaflet
position was considered as the starting stress-free state. The coronary arteries (LCA and
RCA) were incorporated in the full AV model, with coronary ostia located 18-mm above
the aortic annulus, as reported in vivo [129]. The LCA and RCA were modeled with
diameters of 4 mm and 3.2 mm, respectively [129], a thickness of 0.4 mm [130], and their
outlets were extended by 6 mm from the aortic wall (Figure 11c).
Table 3: AV dimensions (mm)
ra

rv

ds

hs

hl

ta

ts

tv

12.5

12.5

6.0

22.1

14.0

1.5

1.5

1.5
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Table 4: Leaflets thickness (mm)
attachment
edge

belly

coaptation
zone

free edge

nodulus of
Aranti

1.16

0.18-0.58

0.68-1.29

1.53

2.06

Figure 11: Base Geometry: (a) one-sixth AV model with dimension parameters, (b)
sectional view of full AV geometry without coronary arteries and (c) top view of
the coronary AV geometry [128]

3.1.1.2. AV Leaflet and Blood Constitutive Models
As a first approximation, the leaflet material was modeled as isotropic and
homogenous. Collagen fibers on the AV leaflets are known to exert extra stiffness at
increased stress in the circumferential direction, causing the non-linear hyperelastic strainstress response of the leaflets. Therefore, a three-parameter Mooney-Rivlin material model
was used to approximate the leaflet mechanical behavior. The strain energy density
function for a three-parameter Mooney-Rivlin material is given by
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W  C10 ( I1  3)  C01 ( I 2  3)  C11 ( I1  3)( I 2  3) ,

(1)

where I1 and I 2 are the two invariants of the Cauchy-Green deformation tensor, and C10 ,
C01 and C11 are material constants calibrated from experimental tensile data obtained from
the literature [131]. The stress-strain curve of the leaflet material predicted by this model
closely matched the response measured experimentally on porcine leaflets (Figure 12
[128]).

Figure 12: Stress vs strain curve of the leaflet material [128]

A fluid density of 1050 kg/m3 and dynamic viscosity of 0.0035 Pa·s were adopted to
approximate blood as a Newtonian, homogenous and incompressible fluid. This
approximation is consistent with several other computational studies on valvular and
vascular blood flow [99], [102], [132].
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3.1.1.3. Boundary Conditions
Flow in the AV was simulated using a near-physiologic transvalvular pressure
profile ranging from 6 mmHg to -94 mmHg at the valvular inlet [128] and zero-gauge
pressure at the outlet. An FSI interface with no-slip condition was set up on the fluid
surfaces in contact with the leaflets. The structural inlet and outlets were fixed to avoid
longitudinal motion. An arbitrary mechanical pressure ranging from 0 to 23 mmHg (3 kPa)
was also imposed on the leaflets during diastole to ensure coaptation. A three-parameter
Windkessel model was applied to the coronary outlets to prescribe physiologic coronary
volume flow rates (LCA: 0.2 L/min and RCA: 0.05 L/min) during the cardiac cycle [22].
3.1.2. Improved Coronary-AV Model
The model described in the previous section was modified to more accurately
simulate the native valvular flow and the leaflet deformation under normal pressure
conditions. This section describes the improvements made to the previous model.
3.1.2.1. Valve Geometry
The new geometry implemented the same overall AV dimensions and leaflet
thickness as in the previous model. Changes were made to improve leaflet coaptation and
numerical stability. In the previous model geometry, the starting position of the leaflets led
to a large gap between the leaflets and improper coaptation during diastole. This issue was
addressed in the new model by increasing the leaflet free-edge length by 1.2 mm in the
radial direction. This geometrical change was achieved practically by displacing the tip
point and the centerline by 1.5 mm towards the center of the valve (Figure 13). The new
leaflet position was considered as the initial stress-free state. In addition, the aortic and
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coronary outlets were further extended to 36 mm and 20 mm, respectively (original: 12
mm and 6 mm, respectively), to let the flow develop and improve computational stability.
The improved AV geometry was designed using SolidWorks 2018 (Dassault Systemes
SE).

Figure 13: Coronary AV geometry: (a) side view showing aortic outlet extension, (b)
top view showing extended LCA and RCA outlets (c) one-sixth sectional view of the
aortic root showing the displaced tip point and the centerline
3.1.2.2. Boundary Conditions
Boundary conditions were specified to simulate valvular flow under normotensive
conditions. A transient and spatially uniform velocity profile calculated from the
physiologic aortic flow rate waveform [133] was prescribed at the valve inlet (Figure 14),
and resulted in a cardiac output of 5 L/min and a systolic-to-diastolic ratio of 1:2.
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Figure 14: Inlet velocity profile

The implementation of the new boundary conditions allowed the aortic outlet to be set
at constant zero-gauge pressure to mimic the native hemodynamic environment, which
contrasted with the previous model which imposed a transvalvular pressure gradient. The
forward flow momentum generated by the inlet conditions allowed the passive opening of
the leaflets during systolic ejection. However, the lack of negative transvalvular pressure
imposed during diastole resulting from this strategy had to be compensated for by
subjecting the aortic leaflet surface to a physiologic diastolic pressure (0 – 80 mmHg,
Figure 15), in order to ensure leaflet coaptation.
An FSI interface with a no-slip condition was set up on the fluid surfaces in contact
with the leaflets. Coronary flow velocities calculated from published physiologic coronary
volume flow rates (LCA: 0.2 L/min and RCA: 0.05 L/min) [134], were specified at the
coronary outlets (Figure 16).
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Figure 15: Mechanical pressure on the leaflet fibrosa

Figure 16: Coronary flow velocity profiles

In the structural setup, the aortic wall was considered rigid to save computational time.
The leaflet surface was defined as a fluid-structure interface and the leaflets were prevented
from penetrating each other during closure by implementing a frictionless contact with a
contact offset of 0.5mm.
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3.1.3. Mesh Generation
The structural and fluid domains were spatially discretized using tetrahedral elements
in ANSYS R19.3. The structural grid consisted of 48,516 elements, which was shown to
be sufficient to yield mesh-independent results in a previous study [22]. For the fluid
domain, a mesh sensitivity analysis was performed to obtain a final computational grid of
629,284 elements (Table 5). The fluid domain was exported at peak systole and was
meshed with different cell sizes. The resulting fluid grids were then used to run a steadystate CFD simulation representative of the peak-systolic conditions. The endpoints
considered to assess numerical convergence included the average velocity captured at a
point located 21 mm downstream of the inlet, the TPG across the valve, and the surfaceaveraged pressure exerted on the NCL. Simulations using the fourth grid size resulted in
less than 1% change in parameter values as compared to the previous grid size. Therefore,
the third grid (average cell size: 0.64 mm; number of elements: 629,284) was chosen as the
final grid size for the fluid domain.
Table 5: Fluid mesh sensitivity analysis

S.no

Cell size
(mm)

Grid size
Average velocity Pressure on
TPG (Pa)
(no of elements) at a point (m/s)
NCL (Pa)

1

1.00

162604

0.73

21.09

173.84

2

0.75

452000

0.69

31.46

169.23

3

0.64

629284

0.67

27.17

164.78

4

0.55

926672

0.67

27.19

163.80
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3.1.4. FSI Modeling Strategy
The investigation of the impact of hypertension on leaflet dynamics required the
accurate assessment of the transfer of momentum between blood flow and the leaflets,
which was fulfilled by employing a FSI modeling strategy. In this approach, the mechanical
data is transferred between the fluid and solid domains through an intermediate system
coupling. The fluid domain transfers force to the structural domain and the resultant
displacement is transferred back to the fluid domain, thereby performing a two-way FSI
coupling (Figure 17a [135]). The cycle was repeated iteratively until a converged solution
was reached for the fluid and structural governing equations, and the system coupler at
every time step (Figure 17b [136]).

Figure 17: Schematic showing 2-way FSI modeling (a) [135] and three levels of
iteration in a transient 2-way FSI simulation (b) [136]
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3.1.4.1. Fluid Domain Description
The governing equations for the fluid domain consisted of the momentum and continuity
equations. The fluid flow equations were formulated in the ALE form as shown below:



 

 V
f 
 ((V  W )  )V     f  f f ,
 t



 f  V  0 ,

(2)

(3)


where  f ,  f and f f are the fluid density, stress tensor and body force per unit volume



and V and W are the velocities of the fluid and moving grid respectively.
The transient flow solution was solved in ANSYS Fluent, which implements a
FVM to discretize the governing equations. Briefly, the domain is first divided into cells.
The governing equations are then integrated in each cell to create algebraic equations
known as discretization. Finally, the algebraic equations are linearized, and a pressurebased solver is used to solve the equations iteratively and to update the fluid pressure and
velocity fields.
3.1.4.1.1. Discretization of Momentum Equation
The unsteady transport equation of a scalar quantity (  ) expressed in an integral form
can be discretized for a given cell volume V as
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V    f v f  f  A f    f  Af SV ,
t
f
f

(4)

where N is the number of faces surrounding the cell,  f is the convection component of 


through the face, v f is the face velocity vector,  is the diffusion coefficient for  , A f is

the face area ( A  Ax iˆ  Ay ˆj in 2D),  f is the facial gradient and S is the source of 
per unit volume. The nonlinear terms in equation 4 are linearized using coefficients  p ,
anb and b for  , nb and  p , respectively, to yield the following equation:

 p   anbnb b ,

(5)

nb

where nb refers to the neighboring cells and P refers to cell center. Equation 5 is then
applied to all cells in the mesh to get algebraic equations with sparse coefficient matrix.
The momentum equation was similarly discretized by substituting  with the velocity
component of the respective momentum equation. For example, the x-momentum equation
is expressed by substituting  with x-velocity component u as shown below:


 p u   anbunb    f A  iˆ  S ,

(6)

nb


where A  iˆ is the face area vector component and S is the source term. The velocity field
can be calculated from this equation if the pressure and face mass flux are known. Like the
scalar quantity  , these values were represented at the cell centers and not at the faces,
which required the use of interpolation schemes. For pressure interpolation, a second-order
upwind scheme was used. The governing equations were also discretized temporally using
a second-order upwind scheme as shown below:
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3.1.4.1.2. Discretization of Continuity Equation
Equation 3 was integrated over the control volume to yield the discretized continuity
equation:
N faces

J

f

Af  0 ,

(8)

f

where J f is the mass flux through f .
The weighing factors obtained from equation 6 were used in a momentum-weighted

averaging-based interpolation scheme to obtain the normal face velocity ( vn ). The face

flux was then expressed as:
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  p c  r0  pc1   p c  r1
0

1

 

1

 ,

(9)

pc0 , pc1 , vn.c0 , vn.c1 represent the pressure and normal velocity component,



respectively, at the cell centers adjacent to the face, r0 and r1 are the distance from the face

to respective cell centers and d f accounts for the averaged coefficients a p from equation
6.
The discretized governing equations were solved iteratively using a pressure-based
solver. An additional pressure condition was developed by correcting the continuity
equation. This corrected pressure equation was used for pressure-velocity coupling. The
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coupled algorithm, which solves the momentum and pressure-based continuity equations
together, was selected as the solver (Figure 18 [137]). The coupled algorithm allows for
faster convergence and is highly adaptable to poor mesh quality during the simulation
compared to other solvers. The solver iteration ended once the convergence residual of
0.001 was reached for the pressure and velocities in the momentum equations.
Due to the dynamic nature of the fluid mesh, smoothing and remeshing settings were
enabled. Spring-based smoothing with a factor of 1 was enabled to move the interior nodes
relative to the boundary nodal displacement. A remeshing strategy was utilized to account
for the degradation of cells due to the large displacement of the boundary. Without
remeshing, the deteriorated cells can cause negative cell volume and convergence issues.
Cells below a certain size and skewness criterion were locally remeshed, and the new cells
that were formed were checked for the same criteria to maintain mesh quality throughout
the simulation.
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Figure 18: Overview of the pressure-based coupled algorithm [137]

3.1.4.2. Structural Domain Description
The structural domain was governed by the momentum equation expressed in
Lagrangian form as:





 s d s    s  f s ,

(10)



where  s is density of the structure, d s are displacement,  s is stress tensor and f s is body
force per unit volume.
The displacements were solved in ANSYS Mechanical, which uses FEM to spatially
discretize the principle of virtual work, and to develop the finite-element semi-discrete
equation of motion as

40





Mu  t   Cu  t   Ku  t   F  t  ,

(11)

where M , C and K are the structural mass, damping and stiffness matrix, respectively,



u  t  , u  t  and u  t  are the nodal acceleration, velocity and displacement vector,

respectively, and F  t  is the external load vector.

Equation 11 was time-integrated using the Newmark method and was reformatted as




Mun 1  Cun 1  Kun 1  Fn 1 ,

(12)

where




un 1  un  1    un   un 1  t ,

(13)

 1

 
 

un 1  un  un t      un   un 1  t 2 ,

 2


(14)

and

Equations 12, 13 and 14 were combined together to replace the integration parameters

 and  with parameters a0 to a7 , and form the single-step time integrator with one
unknown and three known quantities:

 a M  a C  K  u
0

1

n 1








 Fn 1  M a2un  a3un  a4un  C a5un  a6un  a7 un , (15)









un 1 was calculated from above and its time derivatives (i.e., velocity and

acceleration vectors) were then calculated using the following equations:
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un 1  a1  un 1  un   a4un  a5un ,

(16)






un 1  a0  un 1  un   a2un  a3un ,

(17)

Equations 15 to 17 were solved iteratively at every time step using the Newton
Raphson method, until the convergence criterion were achieved. The convergence criterion
was based on the product between the default tolerance value (  R  0.001 ) and the reference
value ( Rref ) obtained from the total applied force:

R   R  Rref ,

(18)

3.1.4.3. System Coupling
The transfer of data between ANSYS Fluent and Mechanical was achieved via the
system coupling module System Coupler 1.0. Three coupling conditions were enforced to
ensure continuity of the data transfer between the solvers:

 
Displacement : d s =d f
 
Velocity : V=d s




,
Traction :  s  nˆs   f  nˆ f 


(19)

where nˆs and nˆ f are the normal unit vectors at the interface for the structure and fluid
domain, respectively. Coupling iterations were also checked for convergence at every time
step. This was achieved when the difference between two successive data transfers fell
below 10-3 for both displacement and force. The minimum and maximum number of
coupling iterations were set to 20 and 50 respectively. The simulation end time was 1.72
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seconds to span two cardiac cycles, and a time-step size of 10 ms was adopted to discretize
each cycle into 86 time steps.
ANSYS Workbench provided a platform to run all the solvers and the coupling module. A
detailed representation of the FSI solution procedure is shown in Figure 19 [136].

Figure 19: Schematic showing the 2-way FSI solution procedure [136]
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3.1.5. Mechanical Characterization
At the end of the simulations, the results were post-processed and the AV
hemodynamics, leaflet WSS environment and the leaflet dynamics were characterized
using different metrics.
3.1.5.1. Leaflet Dynamics
Valvular dynamics was characterized in terms of the geometric orifice area (GOA),
which is the anatomical orifice area of the valve at peak systole. It was computed by
measuring the area of the planar region connecting the lowest points of the free edge of the
leaflets (Figure 20a). Leaflet deformation was qualitatively investigated by comparing the
leaflet profile predicted at different phases of the cardiac cycle. The coapted configuration
of each leaflet in the model was also quantified by calculating a coaptation leaflet angle
defined as the angle between the line tangent to the base of the leaflet and the horizontal
direction (, Figure 20b). Lastly, AV mechanics was also assessed in terms of the leaflet
stretch ratio (  ), which represents the ratio of the deformed length ( l ) to the initial length
( L ) of a line element aligned along a particular direction:



l
L

(20)

The stretch ratios in both radial and circumferential directions were assessed regionally and
globally for all three leaflets.
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Figure 20: GOA measurement plane (a) and leaflet opening angle
measurement scheme (b)

3.1.5.2. Valvular Hemodynamics and WSS Characteristics
The velocity field was assessed in terms of the streamline field and the in-plane
vorticity field captured in the three vertical planes bisecting the leaflets (Figure 21a). The
EOA, peak systolic jet velocity and mean pressure gradient were also quantified. The EOA
was calculated as:
EOA 

Q
,
51.6 P

(21)

where Q is volume flow rate in mL/s, and P is the transvalvular pressure gradient in
mmHg.
The WSS distribution on the leaflets was characterized qualitatively by capturing
the WSS contours and WSS waveforms and quantitatively in terms of temporal shear
magnitude (TSM) and oscillatory shear index (OSI). The TSM represents the timeaveraged WSS magnitude, while the OSI indicates the directionality of the WSS, with a
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value of 0 representing unidirectional/pulsatile flow and a value of 0.5 representing a
bidirectional/oscillatory flow. Those metrics, which are defined as:
T

1
TSM    dt ,
T 0

(22)

 T

    dt  
1
 ,
OSI  1   T0

2
    dt  

  0


(23)

and

respectively, where τ is the instantaneous WSS, and T is the cardiac period, were
computed in the tip, belly and base regions of each leaflet for both the radial and
circumferential WSS components (Figure 21b).

Figure 21: Leaflet planes for vorticity field assessment (a) and leaflet
regions with the radial and circumferential direction (b)
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3.2 Results
The model was run to simulate two cardiac cycles. The results were analyzed for
temporal convergence and the converged results were extracted for further post-processing.
3.2.1. Normotensive AV Hemodynamics
The normotensive model generated a peak-systolic jet velocity of 1.15 m/s, a mean
systolic pressure gradient of 3.46 mmHg and an EOA of 3.84 cm 2. The transvalvular
pressure across the valve during the cardiac cycle was also computed (Figure 22) and the
time-averaged pressure gradient was found to be -10.65 mmHg.

Figure 22: Transvalvular pressure vs. time in the normotensive model

Snapshots of the streamline field was captured throughout the cardiac cycle (Figure
23). The acceleration phase was marked by the opening of the valve leaflets due to the
increase in transvalvular pressure. As the leaflets opened, there was an increase in flow
velocity through the valve orifice. Peak systole was associated with the maximum flow
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velocity (1.15 m/s) and the maximum opening of the leaflets (GOA: 4.47 cm 2). During this
phase, the flow in the sinus region was almost stagnant as the deployment of the leaflets
trapped the blood located within the three aortic sinuses. Streamlines also showed that until
peak systole, coronary flow was reduced due to the myocardial contraction. During the
deceleration phase, the drop in pressure gradient led to a reduction in orifice jet velocity
(36% vs peak systolic velocity) and the rapid closure of the leaflets (24% decrease in GOA
vs peak-systole). Coronary flow velocity showed a slight increase during this phase. During
diastole, the leaflets were fully closed and coapted due to the combination of the negative
transvalvular pressure and the external mechanical pressure applied on the leaflets.
Increased flow velocity was observed during this phase for both LCA and RCA, which
slowly dissipated by the end of diastole.

Figure 23: Streamline field during the acceleration phase (t=80 ms), at peak systole
(t=130 ms), during deceleration phase (t=230 ms) and during diastole (t=400 ms)
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The in-plane vorticity contour and velocity vector fields were captured in the
vertical planes bisecting the leaflets during the acceleration phase, at peak systole, during
deceleration phase and during diastole (Figure 24). The vorticity contours captured
downstream of the three leaflets were largely similar throughout the acceleration phase
until peak systole (t=130 ms). During the deceleration phase, the combination of flow
deceleration and leaflet bending led to vortex shedding and formation of high-magnitude
counterclockwise vortices near the tip of all three leaflets. These vortices are known to
promote valve closure [19], [20]. During early diastole, the tip vortices migrated
downstream of the valve into the aorta and the coronary arteries. This phase was also
characterized by decrease in vorticity magnitude in the sinus region behind the leaflets.
During the rest of diastole, the vortices in the sinuses and downstream of the valve slowly
dissipated. The size and magnitude of the tip vortex slightly varied between the leaflets,
with the LCL and RCL generating stronger vortices than the NCL during the deceleration
phase. The vorticity captured near the belly and base regions of the LCL also exhibited
higher magnitude than those captured in the same regions of the RCL and NCL. This
observation is supported by the calculation of the plane-averaged vorticity, which revealed
a 9.5-fold increase in the LCL plane relative to the NCL plane, and a 9.1-fold increase in
the NCL plane relative to the RCL plane.
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Figure 24: Vorticity and velocity field in the leaflet bisecting planes during the
acceleration phase (t=80 ms), at peak systole (t=130 ms), during deceleration
phase (t=230 ms) and during diastole (t=400 ms and t=560 ms) under
normotensive condition
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3.2.2. WSS Characteristics
The spatial WSS distribution on the fibrosa was captured on each leaflet at five
phases during one cardiac cycle (Figure 25). During the acceleration phase, high WSS
levels were concentrated in the tip of all three leaflets, while a second region of elevated
WSS was also observed near the axis of symmetry of the NCL in the base and belly (1). At
peak systole, the WSS levels predicted in the tip, belly and base of the leaflets were lower
than those captured during the acceleration phase. Increased WSS levels were mostly seen
in the tip of the leaflets with the LCL and NCL contour displaying regions of increased
WSS levels on and in the vicinity of the axis of symmetry (2). During the deceleration
phase, the LCL and RCL exhibited relatively similar WSS distributions marked by several
pockets of elevated WSS along the free edge (3). While those pockets were also present in
the NCL (4), they were typically larger in size and characterized by higher WSS magnitude.
As expected, the progressive loss of flow momentum during diastole was accompanied by
a marked reduction in WSS on the leaflets, and the attenuation of the differences observed
earlier.
The temporal WSS variations over the cardiac cycle were extracted along the radial
(Figure 26) and circumferential directions (Figure 27). These waveforms exhibited the
typical low-oscillatory nature of the WSS environment on the leaflet fibrosa [64], [138],
[139]. Regardless of the leaflet, the highest radial WSS levels were predicted in the tip
region. In contrast, the circumferential WSS waveform did not show any regional
variations in WSS level on the leaflets. Highest radial WSS oscillations were observed in
the base region of leaflets, especially NCL. Unlike the radial WSS waveform, the tip and
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belly region of the leaflets showed high frequency of WSS oscillations in the
circumferential direction.

Figure 25: WSS distribution in the LCL, RCL and NCL fibrosa during the acceleration
phase (t=80 ms), at peak systole (t=130 ms), during deceleration phase (t=230 ms) and
during diastole (t=400 ms and t=560 ms) with four specific regions
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Figure 27: Radial WSS waveform in the tip, belly and base of the LCL, RCL and NCL
fibrosa for the normotensive case

Figure 26: Circumferential WSS waveform in the tip, belly and base of the LCL, RCL
and NCL fibrosa for the normotensive case
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The temporal radial and circumferential WSS characteristics were quantified in
terms of TSM and OSI as reported in Table 6 and Table 7, respectively. Since the flow
direction is dominant in the radial direction on the fibrosa, the radial component of WSS
was expected to be dominant and higher compared to the circumferential component. As
compared to the LCL, the RCL and NCL displayed 2% and 6% increase, respectively, in
leaflet-average radial TSM. The radial TSM increased from the base to the tip of the leaflets
(LCL: 16- and 2-fold increase; RCL: 19- and 2.5-fold increase; NCL: 12.3- and 1.5-fold
increase in the tip and belly, respectively, vs. the base). The leaflet-average circumferential
TSM in the RCL and NCL was 10% and 4% lower than that computed on the LCL,
respectively. Following the trend of the radial TSM, the circumferential TSM increased in
the tip region of the leaflets (LCL: 50% increase; RCL: 60% increase; NCL: 110%
increase) relative to the base. The predictions of the circumferential TSM in the belly
region exhibited an opposite trend (LCL: 40% decrease; RCL: 13% decrease; NCL: 8%
decrease relative to the base). The analysis of the OSI in the radial direction revealed the
oscillatory nature of the flow near the leaflet belly and base regions (OSI > 0.24), which
contrasted with the pulsatile flow characteristics captured near the tip (OSI < 0.15). The
circumferential OSI exhibited pulsatile flow characteristics near the belly and base regions
(OSI < 0.17) and oscillatory flow characteristics near the tip (OSI > 0.29).
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Table 6: Radial TSM and OSI in the regions of LCL, RCL and NCL
Leaflet

TSM (Pa)

OSI

tip

belly

base

tip

belly

base

LCL

1.29

0.16

0.08

0.14

0.32

0.24

RCL

1.32

0.17

0.07

0.14

0.29

0.44

NCL

1.35

0.16

0.11

0.15

0.38

0.28

Table 7: Circumferential TSM and OSI in the regions of LCL, RCL and NCL
Leaflet

TSM (Pa)

OSI

tip

belly

base

tip

belly

base

LCL

0.12

0.05

0.08

0.33

0.15

0.12

RCL

0.11

0.06

0.07

0.29

0.17

0.13

NCL

0.13

0.06

0.06

0.43

0.10

0.12

3.2.3. Leaflet Dynamics
The model predicted a GOA of 4.47 cm2. Leaflet deformation profile was also
visualized during the cardiac cycle (Figure 28). LCL and RCL profiles showed no
qualitative differences throughout the cardiac cycle. NCL profile differed from the other
leaflets only during the deceleration phase.
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Figure 28: Leaflet profiles at peak systole (green), during the deceleration phase
(red) and during diastole (blue) under normotensive condition
The maximum leaflet opening angle of 87.4 was detected at peak systole. The
calculation of the leaflet coaptation angle (Table 8) revealed nearly similar coaptation
profiles on the three leaflets.
Table 8: Leaflet coaptation angle under normotensive condition
Leaflet type

LCL

RCL

NCL

Angle of the leaflet (θ) in
degrees

27.14

27.08

27.01

Radial and circumferential leaflet stretch ratios were evaluated and reported in Table
9. The leaflet-average radial stretch ratio in the RCL and NCL was found to be 5% and 2%
higher than that predicted in the LCL, respectively. The leaflet-average circumferential
stretch ratio was also 4% and 1% higher in the RCL and NCL, respectively, than in the
LCL. The radial stretch ratio increased from the base to the tip of the RCL (8% and 9%
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increase, respectively, vs. the base). LCL and NCL showed almost uniform stretch across
the surface with less than 1% change in the radial stretch characteristics. The
circumferential stretch in the RCL was increased by 7% each in the tip and belly vs. the
base. NCL displayed 2% increase only in the tip vs. the base. LCL showed no variation
across the surface.
Table 9: Regional stretch characteristics on AV leaflets

Maximum radial
stretch

Maximum
circumferential
stretch

tip

belly

base

leaflet
average

LCL

1.01

1.01

1.00

1.01

RCL

1.08

1.10

1.00

1.06

NCL

1.02

1.02

1.03

1.03

LCL

1.01

1.00

1.00

1.00

RCL

1.07

1.07

1.00

1.05

NCL

1.02

1.01

1.00

1.01

The systolic-average and diastolic-average stretch characteristics were also
computed to quantify the increase in stretch during coaptation (Figure 29). Both the radial
and circumferential stretch ratio were increased from the base to the tip region. The radial
stretch was predominant in all the leaflets. Radial diastolic stretch was increased by 32%,
24% and 38% in the LCL, RCL and NCL, respectively, vs the systolic stretch ratio.
Similarly, circumferential stretch ratio during diastole was increased by 25%, 19% and
28% in the LCL, RCL and NCL, respectively, vs the systolic stretch ratio.
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Figure 29: Regional stretch characteristics on AV leaflets during systole and
diastole
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3.3. Discussion
The discussion section includes the comparison of flow characteristics, WSS
environment and leaflet mechanics between the normotensive model of this study with the
data reported in literature as well as the previous coronary-AV model. Lastly, the
limitations of the computational model are also broadly discussed.
3.3.1. Model Validity
The objectives of this first aim were to develop a validated AV computational model
subjected to normotensive conditions, and to generate a reference valvular mechanical
state. The approach consisted of refining a previously published AV geometry including a
functional coronary flow model, and running FSI simulations to predict the flow and the
leaflet dynamics under normotensive conditions and physiologic CO.
AV hemodynamics was characterized by a high velocity flow during the ejection phase
followed by the formation of intense vortices, characterized by strong flow rotationality,
near the tip region of the leaflets during the deceleration phase. Coronary flow resulted in
the suppression of the tip vortices in the left- and right-coronary sinuses during this phase.
The diastolic phase was characterized by a reduction in valvular flow, vortices migration
downstream into the coronary arteries and aorta and its progressive dissipation. These
characteristics are in agreement with other valvular and coronary flow characterizations
reported in computational [98], [128] and in-vitro studies [140], [141]. The predictions of
key flow parameters, such as the mean TPG (3.46 mmHg), peak-systolic jet velocity (1.15
m/s) and EOA (3.84 cm2), were consistent with clinical and experimental data [33], [68],
[97], [142]–[146] (Table 10).
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Table 10: Validation of normotensive flow metrics
Flow metrics

FSI model

Literature

Peak systolic jet velocity (m/s)

1.15

<2

Mean pressure gradient (mmHg)

3.46

<5

EOA (cm2)

3.84

3-4

Regardless of the leaflet, the WSS captured on the fibrosa was found to be lowmagnitude and oscillatory in the base and belly regions. Consistent with previously
published data [73], [128], the WSS predicted on the fibrosa ranged from 0 to 4 Pa
(literature: 0-3.5 Pa), and exhibited increasing magnitude from the base to the tip of the
leaflets. The radial TSM was dominant (one-order of magnitude difference) over the
circumferential TSM on the leaflets, which is consistent with the literature [73], [102],
[128]. The effects of the coronary circulation on the leaflet WSS environment were
suggested by the substantial differences in spatial WSS distribution and WSS magnitude
predicted between the NCL and the LCL/RCL. TSM and OSI predictions also exhibited
increased values in the NCL relative to the LCL/RCL.
Additionally, the GOA, leaflet opening angle and stretch ratios were assessed and
compared with published data to validate the leaflet mechanics. The model estimated a
GOA of 4.47 cm2, which fell within the range of 3-5 cm2 reported by clinical studies [147],
[148]. The maximum leaflet opening angle (87.4) was also consistent with the range
reported in the literature (85-94) [149], [150]. Stretch ratios increased from the base to the
tip of the leaflets, and the radial component was found to be slightly larger and dominant
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by 2% over the circumferential stretch, consistent with previous reports [101], [118]. The
present coronary-AV model was able to capture the native flow and WSS environment and
the leaflet mechanics under normotensive condition. Overall, these characteristics
demonstrated the validity of the present model to simulate physiologic blood flow and
leaflet deformation under different pressure conditions.
3.3.2. Model Improvements vs. Previous Models
The present coronary-AV model was developed from a previous model with
improvements made to the geometry and boundary conditions. These improvements
resulted in the following mechanical variations:


Increase in the leaflet free-edge length enabled coaptation with reduced gap
between the leaflets during diastole (26.5% lower) relative to the previous model



Extension of the valve and coronary outlets helped in flow development and
numerical stability



The use of velocity profile at the inlet enforcing a physiologic CO of 5 L/min
resulted in a GOA of 4.47 cm2 mimicking native valve function more closely than
the previous model, which generated a CO of 4.3 L/min and a GOA of 3.7 cm 2



Leaflet closure was achieved by subjecting the leaflets to a diastolic pressure
condition of 80 mmHg matching the native aortic pressure value. This improvement
over the previous model, which implemented a non-physiologic pressure of 22.5
mmHg, resulted in near-native leaflet deformation during diastole

The improvements made in the present model allowed for the generation of physiologic
leaflet deformation and flow characteristics in the AV. Overall, a computational coronary61

AV model capable of simulating native blood flow under normotensive condition was
developed, and successfully validated using different qualitative and quantitative
measures. Hence, this model was used as a reference model in the subsequent aims.
3.3.3. Limitations
A number of simplifications were made to the model and the methodology. These
simplifications were consistent to the ones considered in other computational studies [92],
[101], [128], [151]–[153].
The main limitations are the use of an approximated leaflet material and the
prescription of a zero outlet gauge pressure instead of the physiologic aortic pressure
profile. The anisotropy of the leaflet material due to the orientation of the elastin and
collagen fibers was neglected. Instead, the leaflet material was assumed isotropic in order
to prevent structural element distortion. This assumption was justified as results from a
previous study implementing an isotropic model [128] showed only limited differences in
leaflet mechanics relative to models implementing an anisotropic leaflet material [154],
[155]. However, flow resistance is dependent on the leaflet material, which is hindered due
to this approximated leaflet model. Therefore, to achieve the CO of 5 L/min, a constant
non-physiologic zero-gauge pressure was used, effectively subjecting the valve to a nonphysiologic transvalvular pressure gradient. This difference between the native
transvalvular pressure and the transvalvular pressure captured by the model is essential in
achieving the physiologic CO under normotensive condition.
Secondly, the valvular geometry was designed with three identical, equiangularly
spaced sinuses and leaflets. This is a simplification of the native aortic root, which consists
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of non-identical leaflets and sinuses, and generates leaflet-specific stress environments
[80]. Hence, improving the valve geometry should be addressed in a future model.
Blood flow in the native AV transitions from laminar to turbulent at peak systole.
However, the flow was modeled as laminar. This assumption was made to limit the
complexity of the FSI model, and reduce computational time and cost. A justification for
this assumption was also provided by a previous computational study that found no
substantial difference in overall flow structure between a laminar and a turbulent AV model
[156]. Lastly, the use of the ALE method required to maintain a single fluid domain
throughout the cardiac cycle. This was achieved by using a very low contact offset in the
structural domain, which prevented the leaflets from completely closing and splitting the
fluid domain during leaflet coaptation. In doing so, a small orifice was still present even
after closure, which led to a very low amount of valvular regurgitation. The prediction of
the velocity along the y-axis at a point and the volume flow rate at a plane, both upstream
of the leaflets, yielded 0.018 m/s and 4.510-7 m3/s, respectively (i.e., 44% and 59%
decrease, respectively, vs. the previous model), suggesting the near absence of
regurgitation in the model. This low regurgitation could be completely avoided by adopting
computational methodologies such as overset meshing or traditional fixed-grid methods.
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CHAPTER 4:
SPECIFIC AIM 2: To quantify AV hemodynamics and leaflet dynamics under
hypertensive conditions
The main objective of this aim was to quantify the alterations in AV hemodynamics,
regional leaflet WSS characteristics and leaflet dynamics under prehypertensive
(PreHTN) and stage-1 hypertensive (HPN) conditions. The same computational
strategy as that designed in Aim 1 was implemented and adapted to simulate AV flow
under hypertension. Boundary conditions representing PreHTN and HPN conditions
were determined and prescribed in the model. AV hemodynamics was analyzed in terms
of velocity and vorticity fields. WSS characteristics (TSM, OSI) were computed locally
on the leaflet surface, and leaflet dynamics was investigated by capturing the leaflet
deformation profile, coaptation angle and stretch ratios.
4.1. Methods
The same geometry, spatial discretization, material models and FSI modeling
strategy as in Aim 1 were considered in this aim. However, the PreHTN and HPN
models implemented different boundary conditions at the outlet of the valve.
4.1.1. Boundary Conditions
4.1.1.1. AV Inlet and Coronary Outlet Conditions
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The same velocity profile as in the normotensive model was prescribed at the
valvular inlet of the PreHTN and HPN models in order to maintain the same physiologic
cardiac output. Although the increase in aortic pressure associated with HPN is expected
to increase diastolic coronary flow and myocardial perfusion, the coronary autoregulation
mechanism compensates for this effect by triggering the remodeling of the coronary
arteries and increasing coronary flow resistance. The flow simulations under PreHTN and
HPN conditions accounted for this mechanism and assumed the maintenance of
physiologic coronary flow levels by imposing the same transient coronary outlet velocity
as in the normotensive model. The external mechanical pressure imposed on the leaflets
was also similar to that implemented in the normotensive model.
4.1.1.2. Aortic Outlet Pressure Conditions
While the normotensive model operated with a zero-gauge pressure at the aortic outlet,
non-zero pressure conditions had to be determined to replicate the increase in aortic
pressure under PreHTN (125/80 mmHg) and HPN (130/90 mmHg). In a simple onedimensional representation, the flow rate (Q) and the pressure gradient across the valve
(P) are related by the valvular flow resistance (R) as:
R

P
Q

(24)

A physiologic AV flow resistance enables the maintenance of a physiologic CO of
5 L/min under normal aortic pressure conditions (120/80 mmHg). However, given the
strong dependence of R on the leaflet material, and the approximation made by the
isotropic, homogeneous Mooney-Rivlin model, the effective resistance in the
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normotensive model was expected to differ from the native AV resistance. As a result, the
production of a physiologic CO in the normotensive model was expected to be achieved
under a non-physiologic pressure gradient across the valve. Therefore, the determination
of appropriate outlet pressure conditions ( Paortic ) reflecting an actual increase in aortic
pressure ( Paortic ) of +5 and +10 mmHg under PreHTN and HPN, respectively, required: 1)
the assessment of the actual time-averaged pressure gradient across the normotensive
model ( P model ), and 2) its comparison to the physiologic time-averaged pressure gradient
across the native AV ( P physio  44 mmHg) via the calculation of a pressure scaling factor
(   P physio P model ), and 3) the determination of the scaled gauge pressure to be
prescribed at the aortic outlet ( Paortic  Paortic  ).
The mean transvalvular pressure gradient predicted across the normotensive AV
model over one cardiac cycle was P model  10.65 mmHg, which resulted in a pressure
scaling factor   4.13 . The resulting scaled increase in aortic pressure to model PreHTN
and HPN was calculated as Paortic  1.21 mmHg (161.4 Pa) and Paortic  2.42 mmHg (322.8
Pa), respectively. Since the increase in aortic pressure under PreHTN is only effective
during the systolic phase, this boundary condition was only enforced during systole and
then switched to zero gage pressure for the rest of the cardiac cycle (Figure 30a). In
contrast, for HPN, which imposes a sustained elevated aortic pressure throughout the cycle,
the scaled increase in aortic pressure was prescribed throughout the cardiac cycle (Figure
30b).
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Figure 30: Aortic pressure during the cardiac cycle in the prehypertensive (a) and
hypertensive case (b)
4.2. Results
4.2.1. Flow Characteristics
The vorticity contour and velocity vector fields in the LCL, RCL and NCL plane
under PreHTN (Figure 31) and HPN (Figure 32) were assessed and compared qualitatively.
Until peak systole, both models exhibited essentially similar vortex dynamics, suggesting
the weak dependence of AV hemodynamics on systolic aortic hypertension. During the
deceleration phase, intense vortices associated with strong flow rotationality were observed
near the tip and belly regions of the leaflets in both the PreHTN and HPN condition. At the
onset of diastole, the PreHTN condition exhibited weak vortices in the aortic sinus, while
the HPN condition predicted moderate vortices near the belly and base regions of the
leaflets. The vortices in the sinus and near the leaflets slowly dissipated into the coronary
arteries and the aorta during the rest of the diastolic phase. This observation is supported
by the calculation of the plane-averaged vorticity, which revealed a 9.1-fold increase in the
LCL plane relative to the NCL plane, and an 8.5-fold increase in the NCL plane relative to
the RCL plane under PreHTN (Figure 33). HPN condition predicted a 9.3-fold increase in
the LCL plane relative to the NCL plane, and a 9.3-fold increase in the NCL plane relative
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to the RCL plane. HPN condition contributed to 28.7%, 15.3% and 27.2% increase in
plane-averaged vorticity in the LCL, RCL and NCL, respectively, vs. the PreHTN
condition.

Figure 31: Vorticity and velocity field in the leaflet bisecting planes during the
acceleration phase (t=80 ms), at peak systole (t=130 ms), during deceleration phase
(t=230 ms) and during diastole (t=400 ms and t=560 ms) under prehypertension
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Figure 32: Vorticity and velocity field in the leaflet bisecting planes during the
acceleration phase (t=80 ms), at peak systole (t=130 ms), during deceleration phase
(t=230 ms) and during diastole (t=400 ms and t=560 ms) under hypertension
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Figure 33: Average vorticity measured in the LCL, RCL and NCL plane
under prehypertension and hypertension
4.2.2. WSS Characteristics
The WSS distributions on the fibrosa of the LCL, RCL and NCL were captured at
different phases of the cardiac cycle in the PreHTN (Figure 34) and HPN condition (Figure
35). During the acceleration phase, alterations in WSS spatial distribution were observed
on either side of the axis of symmetry on the leaflets and also along the NCL axis under
the PreHTN and HPN condition (1). At peak systole, both models predicted increased WSS
levels in the tip and the belly of the LCL and RCL. The NCL contour exhibited regions of
increased WSS levels in the tip region only (2). During the deceleration phase, the LCL
and RCL exhibited comparatively similar WSS distributions characterized by several
pockets of elevated WSS along the free-edge and the belly region (3) under both PreHTN
and HPN condition. In the NCL, these pockets were larger in size and were characterized
by higher WSS magnitude in the PreHTN condition only. Diastole was marked by a
reduction in WSS on the leaflets in the HPN condition, with the RCL displaying the highest
WSS levels in the tip and belly region relative to other leaflets. The rest of the diastolic
phase was characterized by the attenuation of WSS levels. HPN condition displayed
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increase in WSS level in the tip of the LCL and reduction in WSS level in the tip and belly
regions of RCL and NCL, relative to the PreHTN condition.

Figure 34: WSS distribution in the fibrosa of the LCL, RCL and NCL
under prehypertensive condition during different phases of the cardiac
cycle

Figure 35: WSS distribution in the fibrosa of the LCL, RCL and NCL
under hypertensive condition during different phases of the cardiac cycle
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The temporal WSS variations over the cardiac cycle were extracted along the radial
(Figure 36) and circumferential directions (Figure 37). Similar to the normotensive model,
these waveforms revealed the typical low-oscillatory nature of the WSS environment on
the leaflet fibrosa, and high radial WSS levels in the tip region. The radial WSS waveforms
revealed essentially similar WSS oscillations and frequency in both the preHTN and HPN
models. The belly region of the NCL exhibited reversal in WSS directionality during
systole under the HPN condition, which was not a feature predicted by the PreHTN model.

Figure 36: Temporal variations of the radial WSS in the tip, belly and base of the LCL,
RCL and NCL under normotensive pressure, prehypertension and stage-1 hypertension
The circumferential WSS waveforms displayed reversal in WSS directionality in the
HPN condition but not in the PreHTN condition. The waveforms captured under HPN
condition also revealed smaller WSS oscillations on the LCL and RCL than under PreHTN
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condition. The tip region of the NCL showed increased oscillations under HPN condition,
compared to the PreHTN condition.

Figure 37: Temporal variations of the circumferential WSS in the tip, belly and base
region of the LCL, RCL and NCL in the radial direction under normotensive pressure,
prehypertension and stage-1 hypertension
These qualitative observations were supported by the analysis of the regional TSM
and OSI predictions for both WSS components (Table 11 and Table 12, respectively). The
HPN condition reported higher radial WSS magnitude (0.09<TSM<1.93 Pa) across the
fibrosa compared to the PreHTN condition (0.07<TSM<1.93 Pa). The most significant
difference between PreHTN and HPN radial TSM was measured at the base region of the
leaflets (37%, 23% and 57% increase on the LCL, RCL and NCL, respectively in the HPN
condition vs. the PreHTN condition). The circumferential TSM was one-order-ofmagnitude lower than the radial TSM, consistent with the normotensive condition. The
HPN condition reported higher circumferential WSS magnitude (0.04<TSM<0.11Pa)
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across the fibrosa compared to the PreHTN condition (0.05<TSM<0.1 Pa). HPN condition
also yielded a 44% and 32% increase in TSM in the tip region of LCL and NCL,
respectively, relative to the PreHTN condition .
WSS directionality in the radial direction was found to be mostly unidirectional in the
tip region of the leaflets and bidirectional in the base region for both the PreHTN and HPN
condition. The belly region of the LCL and RCL also experienced bidirectional WSS under
PreHTN condition. Similarly, the RCL belly also exhibited bidirectional WSS under HPN
condition. HPN condition contributed to a 0.17-point increase in OSI in the base region of
LCL and NCL, relative to the PreHTN condition. Circumferential OSI data revealed mostly
bidirectional WSS in the tip region of the leaflets under PreHTN condition and
unidirectional WSS in the tip of the leaflets under HPN condition. The belly and base
region were exposed to mostly unidirectional WSS. HPN condition predicted 0.34- and
0.42- point decrease in OSI in the LCL tip and base region, respectively, relative to the
PreHTN condition.
Table 11: Radial TSM and OSI data in the tip, belly and base of the leaflets under
prehypertension and hypertension
Prehypertension
Leaflet

TSM (Pa)
tip

belly base

Hypertension

OSI
tip

TSM (Pa)

belly base

tip

belly base

OSI
tip

belly base

LCL

1.87 0.21 0.07 0.10 0.23 0.31 1.87 0.24 0.10 0.15 0.18 0.47

RCL

1.93 0.21 0.07 0.13 0.35 0.45 1.93 0.23 0.09 0.15 0.28 0.45

NCL

1.84 0.21 0.07 0.08 0.11 0.31 1.82 0.22 0.12 0.14 0.19 0.48
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Table 12: Circumferential TSM and OSI data in the tip, belly and base of the leaflets
under prehypertension and hypertension
Prehypertension
Leaflet

TSM (Pa)

Hypertension

OSI

TSM (Pa)

OSI

tip

belly base tip belly base tip belly base tip belly base

LCL

0.08

0.05 0.05 0.46 0.07 0.50 0.11 0.05 0.04 0.12 0.08 0.08

RCL

0.10

0.08 0.05 0.26 0.10 0.19 0.10 0.04 0.04 0.34 0.29 0.15

NCL

0.08

0.08 0.05 0.20 0.32 0.19 0.11 0.06 0.06 0.17 0.16 0.27

4.2.3. Leaflet Dynamics
Leaflet profile was investigated visually at different phases of the cardiac cycle in the
PreHTN and HPN models (Figure 38). The leaflet profiles were similar during systole for

Figure 38: Leaflet deformation profile at peak systole (green), during deceleration
phase (red) and during diastole (blue) under prehypertension and hypertension
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both pressure conditions. During diastole, the HPN condition for all leaflets showed
increase in leaflet coaptation profile, characterized by the increased leaflet curvature,
compared to the PreHTN condition.
The leaflet coaptation angle for the PreHTN and HPN condition were quantified
(Table 13). HPN condition predicted a substantial decrease in coaptation angle in the
leaflets (25%, 25% and 26% decrease in the LCL, RCL and NCL, respectively, relative to
the PreHTN condition).
Table 13: Leaflet coaptation angle under prehypertension and hypertension
Leaflet
type

Pressure condition

LCL

RCL

NCL

Angle of
the leaflet
(θ) in
degrees

Prehypertension

25.87

25.33

25.20

Stage-1 hypertension

19.36

19.02

18.88

Leaflet mechanics was also assessed by evaluating the regional leaflet stretch ratios
in the radial and circumferential direction under PreHTN (Table 14) and HPN conditions
(Table 15). PreHTN and HPN condition predicted up to 8% increase in radial and
circumferential stretch ratio in the tip and belly of the RCL, relative to the base region.
LCL and NCL regional stretch ratios were found to be homogenous throughout the fibrosa
under PreHTN and HPN conditions. HPN condition contributed to up to 3% and 2%
increase in radial and circumferential stretch, respectively, in both the base and belly region
of NCL, relative to the PreHTN condition.
The systolic-average and diastolic-average stretch characteristics on the leaflets
were computed under PreHTN (Figure 39) and HPN conditions (Figure 40). PreHTN
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condition contributed to an overall increase in diastolic radial stretch by 33%, 28% and
39% in the LCL, RCL and NCL, respectively, vs. the systolic stretch ratio. Similarly,
circumferential stretch ratio during diastole was increased by 26%, 20% and 29% in the
LCL, RCL and NCL, respectively, vs. the systolic stretch ratio under PreHTN condition.
HPN condition resulted in increased diastolic radial stretch (39%, 30% and 45% increase
in the LCL, RCL and NCL, respectively) and increased diastolic circumferential stretch
(29%, 23% and 31% increase in the LCL, RCL and NCL, respectively) vs. the systolic
stretch ratio.
Table 14: Regional stretch characteristics under prehypertension

Maximum radial
stretch
Maximum
circumferential
stretch

Leaflet

tip

belly base

LCL
RCL
NCL
LCL
RCL
NCL

1.03
1.09
1.06
1.01
1.08
1.02

1.03
1.10
1.06
1.01
1.07
1.02

1.03
1.01
1.06
1.01
1.00
1.01

leaflet
average
1.03
1.07
1.06
1.01
1.05
1.02

Table 15: Regional stretch characteristics under hypertension

Maximum radial
stretch
Maximum
circumferential
stretch

Leaflet

tip

belly base

LCL
RCL
NCL
LCL
RCL
NCL

1.04
1.09
1.09
1.01
1.08
1.04

1.04
1.11
1.09
1.01
1.08
1.04
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1.03
1.04
1.09
1.01
1.02
1.03

leaflet
average
1.04
1.08
1.09
1.01
1.06
1.04

Figure 39: Regional stretch characteristics on AV leaflets during systole and
diastole under prehypertension
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Figure 40: Regional stretch characteristics on AV leaflets during systole and
diastole under hypertension
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4.3. Discussion
The main objective of this second aim was to characterize the hemodynamic changes
experienced by the AV under PreHTN and HPN conditions. The approach consisted of
substituting the aortic outlet boundary conditions with the PreHTN and HPN aortic
pressure and running FSI simulations to predict the effect on flow and the leaflet dynamics
under HPN conditions. This was achieved by comparing the results of the HPN models
relative to the normotensive model as discussed below:
4.3.1. Effects of Hypertension on AV Hemodynamics
HPN condition predicted increase in vorticity magnitude near the tip region during
systole and in the vicinity of the belly and base region of the leaflets during diastole,
relative to the normotensive condition. Plane-average vorticity was increased in a pressuredependent manner in the leaflets with HPN contributing to 36%, 31% and 34% increase in
flow vorticity in the LCL, RCL and NCL, respectively, relative to the normotensive
condition.
These alterations in flow rotationality under PreHTN and HPN conditions led to
subsequent alterations in WSS magnitude and directionality in the leaflets. WSS overloads
were detected on the leaflets (up to 24%, 22% and 13% increase in leaflet-average TSM in
the LCL, RCL and NCL, respectively, under PreHTN condition and up to 40%, 33% and
27% increase in leaflet-average TSM in the LCL, RCL and NCL, respectively, under HPN
condition, relative to the normotensive condition). This variation in WSS environment
between the coronary and non-coronary leaflets could be associated with the impact of
coronary flow on the leaflet mechanics. Unlike the PreHTN condition, HPN condition also

80

predicted an increase in TSM in the base region of the leaflets (37%, 22% and 10% increase
in TSM in the LCL, RCL and NCL, respectively, vs the normotensive condition).
WSS bidirectionality characteristics were also affected in the PreHTN and HPN
conditions. OSI predictions revealed site-specific alterations on the leaflets, marked by a
pressure-dependent increase in WSS oscillation on the base and a pressure-dependent
increase in WSS pulsatility in the tip region of the leaflets. PreHTN and HPN condition
predicted 0.27- and 0.2-point decrease in OSI in the NCL belly, respectively, relative to
the normotensive condition. HPN condition also predicted a 0.23- and 0.19-point increase
in OSI in the base of LCL and NCL, respectively, relative to the normotensive condition.
Overall, HPN condition contributed to alterations in vorticity dynamics, increased WSS
magnitude and alterations in WSS bidirectionality on the AV leaflets. The increased
bidirectionality and low WSS magnitude on the leaflets especially, the NCL might explain
its high susceptibility to calcification [157]. HPN condition also predicted increased TSM
and OSI in the base region of the leaflets, which have been demonstrated to be the primary
site of calcification [158], [159].
4.3.2. Effects of Hypertension on Leaflet Dynamics
HPN condition predicted increase in leaflet coaptation profile (29%, 30% and 30%
decrease in coaptation angle in the LCL, RCL and NCL, respectively, vs. the normotensive
condition). Leaflet radial stretch also increased in a pressure-dependent manner (LCL: 2%
and 3% increase and NCL: 3% and 6% increase, respectively, under PreHTN and HPN
condition, vs. the normotensive condition). Similarly, HPN condition estimated up to 2%
increase in the circumferential stretch in the NCL, vs. the normotensive condition. The
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diastolic vs. systolic stretch characteristics was increased by 5% radially and 3%
circumferentially in the leaflets under HPN condition, vs. the normotensive condition.
The present study suggested the increase in leaflet deformation under HPN condition.
Overall, PreHTN and HPN condition predicted pressure-dependent increase in radial
stretch characteristics. This increased stretch was predominantly seen in the NCL,
suggesting the high impact of coronary flow on leaflet deformation. Circumferential stretch
was also increased in the leaflets but was lower as expected. The low increase in
circumferential stretch in the leaflets can be explained by the additional stiffness of the
leaflets in circumferential direction [118]. Overall, these results strongly highlight the
effect of increased aortic pressure on AV leaflet dynamics.
4.3.3. Potential Implications for CAVD Pathogenesis
The present study suggests the presence of valvular flow abnormalities and abnormal
hemodynamic stress environment on the AV leaflets. The results from this specific aim
validate the initial hypothesis. HPN conditions predicted WSS overloads and alterations in
WSS bidirectionality on the AV leaflets in a pressure-dependent manner. A previous
mechanobiological study has demonstrated the promotion of inflammation and remodeling
(hallmarks of CAVD) on the leaflet tissue, when exposed to increased WSS magnitude and
alterations in WSS bidirectionality [64]. That study revealed that increased WSS
magnitude promoted the upregulation of BMP-4 and TGF-β1, a characteristic of
inflammation. Results also showed that remodeling was characterized by the upregulation
of MMP-2 and MMP-9 under combined alterations of WSS magnitude and bidirectionality.
The present study also suggested an increase in leaflet stretch characteristics in both
directions under HPN condition. Increased cyclic stretch has been shown to promote
82

remodeling by the upregulation of proteolytic enzymes such as MMP-1, MMP-2 and
MMP-9 [160]. Another in-vitro study has also reported evidence of valvular calcification
under altered stretch in a BMP-dependent manner [161].
Therefore, based on the findings of this study and demonstrated sensitivity of AV
leaflets to abnormal WSS environment and stretch alterations, this study suggests the
existence of a mechanobiological etiology for CAVD in HPN patients. However, further
validation using in-vitro techniques is needed to conclude the findings of this aim and to
ascertain the potential hemodynamic role of HPN in CAVD development. Once that’s
demonstrated, different clinical strategies of diagnosis and treatment could be designed to
isolate the vulnerable population, slow the progression of HPN using antihypertensive
medications, address any flow abnormalities early on or block the pathological cascades at
the later stages.
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CHAPTER 5:
SPECIFIC AIM 3: To investigate the effects of hypertension on coronary resistance and
LV workload
The main objective of this aim was to investigate the long-term effects of hypertension on
coronary flow resistance and LV workload. Myocardial perfusion is maintained across a
wide range of aortic pressure via an autoregulation mechanism. Coronary flow resistance
is therefore expected to increase under elevated aortic pressure in order to maintain
physiologic coronary flow levels. However, the extent to which coronary resistance
changes under PreHTN and HTN is unknown. Similarly, HTN has been associated with
increases in ventricular mass and workload but this association has not yet been
quantified. For this purpose, the models from Aim 1 and Aim 2 were revisited, and
coronary flow resistance and LV work were computed and compared for the different
pressure conditions.
5.1. Methods
5.1.1. Coronary Flow Resistance Calculation
Coronary flow resistance was computed in the LCA and RCA for all pressure
conditions to characterize the effects of hypertension on coronary perfusion and arterial
remodeling. The transient LCA and RCA outlet pressures were extracted from the
normotensive, PreHTN and HPN models. The instantaneous coronary perfusion pressure
( P ) in each coronary artery was then evaluated as the difference between the aortic
outlet pressure and
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the coronary outlet pressure at each time step. The instantaneous coronary flow resistance
(R) was then calculated as
R

P
,
Q

(25)

where Q is the instantaneous coronary volume flow rate. This resistance was then averaged
over the systolic and diastolic phases to obtain the average coronary flow resistance for
systole and diastole. Coronary flow resistance is expected to be higher during systole than
diastole due to the myocardial contraction.
Additionally, the benefits of the coronary remodeling process were quantified by
running new simulations aimed at predicting the flow through the valve under stage-1
hypertension in the absence of coronary remodeling. This was achieved practically by
running the HPN model from Aim 2 using the same coronary flow resistance (i.e., same
coronary outlet pressures) as that computed in the normotensive model. All other
conditions remained the same in this non-remodeling hypertensive (nHPN) model.
Flow results were assessed in terms of the vorticity-velocity fields captured in the
vertical planes bisecting the coronary leaflets, and coronary flow rates were quantified at
the coronary outlets of the nHPN model. Coronary flow metrics such as the peak diastolic
velocity, diastolic-systolic velocity ratio, (i.e., ratio of average diastolic to systolic coronary
flow velocity [162]), and the baseline coronary flow rate (i.e., product of the peak velocity
and the cross-sectional area of the arterial lumen [163]) were also calculated. These results
were then compared with those predicted by the HPN model from Aim 2.
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5.1.2. Stroke Work Calculation
The LV workload or stroke work (W) is defined as the work done by the LV to pump
the stroke volume (SV) during a cardiac cycle. From a thermodynamic perspective, the
exact value of the stroke work can be obtained by calculating the area of the region enclosed
within the contour representing the LV pressure-volume (P-V) relationship over one
cardiac cycle:
W  

cycle

(26)

PdV ,

where P represents the instantaneous ventricular pressure and V

represents the

instantaneous LV volume. Therefore, the LV workload for each pressure condition was
calculated by first plotting the P-V curve and then approximating the enclosed area using
a trapezoidal numerical integration method. The transient LV pressure for each case was
directly extracted from the computed valvular inlet pressure, while the temporal variations
in LV volume (which were not modeled) were obtained from the literature [133].
5.2. Results
5.2.1. Coronary Flow Resistance
Average coronary flow resistances during systole and diastole were calculated for the
LCA (Figure 41) and the RCA (Figure 42) under normotensive, PreHTN and HPN
conditions. Both systolic and diastolic coronary flow resistances were found to increase in
a pressure-dependent manner. Under PreHTN condition, the systolic and diastolic LCA
resistance increased by 79% and 10%, respectively, relative to the normotensive condition.
Under HTN condition, this increase rose by 168% and 140%, respectively. Similarly, the
systolic and diastolic RCA resistance increased by 20% and 27%, respectively, under
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PreHTN condition relative to the normotensive condition. Under HPN condition, this
increase was 45% and 409%, respectively.

Figure 41: Coronary flow resistance in the LCA during systole and diastole
under normotensive, prehypertensive and hypertensive condition

Figure 42: Coronary flow resistance in the RCA during systole and diastole
under normotensive, prehypertensive and hypertensive condition
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In the absence of coronary remodeling, the nHPN condition revealed a substantial
derangement in flow structure (Figure 43), characterized by increase in vorticity magnitude
due to the diastolic increase in coronary flow (up to 13- and 47-fold increase in LCA and
RCA flow rate, respectively) relative to HPN condition (Figure 44). The nHPN condition
predicted increases in peak diastolic velocity, diastolic-systolic velocity ratio, and baseline
coronary flow rate in the LCA (3.8-, 1.2- and 3.9-fold increase, respectively) and RCA
(14.6-, 1.6- and 13-fold increase, respectively), relative to the HPN condition.

Figure 43: Vorticity-velocity field in the LCL and RCL plane during diastole in
the HPN and nHPN condition
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Figure 44: Coronary flow rates in the LCA (a) and RCA (b) in the HPN and nHPN
condition
5.2.2. LV Workload
The LV P-V diagrams were plotted for the normotensive, PreHTN and HPN
conditions (Figure 45). The PV curve under all three pressure conditions were
characterized by the typical ventricular filling (marked by pressure decrease at the start and
slow increase with increase in volume), isovolumetric contraction, ejection (marked by
volume decrease with pressure increase to peak value followed by pressure attenuation)
and isovolumetric relaxation phase. The most substantial alterations to the normotensive
P-V response were exhibited by the HPN model during the contraction, relaxation and
ejection phase. The stroke work increased by 21% in the PreHTN condition, and by 50%
in the HPN condition, relative to the normotensive condition (Figure 46).
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Figure 45: LV P-V chart under normotensive, prehypertensive and
hypertensive condition

Figure 46: Stroke work calculated under normotensive, prehypertensive
and hypertensive condition
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5.3. Discussion
5.3.1. Effect of Hypertension on Coronary Flow Resistance
Coronary remodeling is essential to the maintenance of myocardial perfusion. During
the remodeling process, the increase or decrease in resistance ensures constant flow
through the coronary arteries. Coronary autoregulation ensures the maintenance of constant
flow despite changes in aortic pressure such as those caused by HPN. Hence, coronary flow
resistance was expected to increase under hypertension to compensate for the increased
aortic pressure and to account for arterial remodeling and coronary autoregulation. As
compared to the normotensive condition, HPN condition resulted in increased coronary
flow resistance (LCA: 168% and 140% increase and RCA: 45% and 409% increase,
respectively, during systole and diastole). This increase in coronary flow resistance is a
characteristic of the remodeling and autoregulation process discussed above. Thus, this
study highlighted the process of physiologic coronary remodeling under HPN conditions
via increase in flow resistances.
The significance of coronary remodeling was also demonstrated in the results of the
nHPN condition. Results predicted substantial increases in coronary flow rates and flow
parameters. Increase of these coronary flow parameters have commonly been associated
with coronary artery disease [164]–[166]. However, it is well known that autoregulation
maintains constant coronary perfusion under elevated pressure, as shown by the increased
flow resistance in this aim. Therefore, the changes seen under the nHPN condition are not
physiologic and cannot be associated with any coronary artery complications. These results
only highlight the importance of autoregulation and coronary remodeling, whose absence
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would otherwise lead to drastic effects on the coronary flow as shown by the nHPN
condition.
Overall, this study quantified the effects of HPN on the coronary flow by
characterizing the increase in flow resistance, which is crucial to the maintenance of
myocardial perfusion.
5.3.2. Effect of Hypertension on LV Functionality
LV workload was assessed using P-V chart and stroke work evaluations. The P-V
chart obtained in the normotensive model was compared with the ones reported in
ventricular studies and was shown to represent relatively similar pressure and volume at
the start and the end of the filling phase [167], with a maximum difference below 20 % for
both quantities. The stroke volume was measured at 77.8 mL, consistent with physiologic
and published values (70-80 mL) [144], [167], and the stroke work was calculated at 1.18
J, close to the value reported (1.08 J) [168].
Ventricular overloads were measured in the PreHTN and HPN conditions (21% and
50% increase, respectively, relative to the normotensive condition). This increase in
ventricular workload is normally associated with increase in muscular mass and thickness
of the LV wall, leading to LV hypertrophy [169]. Therefore, this present study suggests a
strong association between HPN and LV hypertrophy. However, further analysis is
required to fully develop that association.

92

CHAPTER 6:
CONCLUSION
In this thesis, a 3D coronary-AV model was designed, and fluid-structure simulations were
performed using an ALE-FSI modeling strategy. The thesis studied the effects of
hypertension on the hemodynamic stress environment of AV leaflets, coronary flow
resistance and LV functionality. Three research questions were formulated at the start of
this study (see chapter 2) and were addressed by the results from Aims 1 – 3.
Does hypertension affect the hemodynamic stress environment on the AV leaflets, And to
what extent?
This study demonstrated the existence of altered hemodynamic stress environment on
the AV leaflets via increased spatial and temporal variation in WSS characteristics in a
pressure-dependent manner, both regionally and globally. HPN led to increased WSS
magnitude on the leaflets exhibited by the 40%, 33% and 27% increase in TSM in the LCL,
RCL and NCL, respectively, relative to the normotensive condition. HPN condition also
predicted increased WSS bidirectionality in the leaflet base, shown by the 0.23-and 0.19point increase in OSI in the LCL and NCL, respectively, relative to the normotensive
condition. Increased WSS magnitude and altered WSS bidirectionality were recorded
across the fibrosa, regardless of the leaflet type, thereby, suggesting the presence of
abnormal WSS environment on the AV leaflets under HPN condition.
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What is the impact of hypertension on coronary flow and the maintenance of myocardial
perfusion?
In specific aim 3, coronary flow resistance was characterized under normotensive and
HPN conditions. The HPN condition contributed up to 168% and 400% increase in
resistance in the LCA and RCA, respectively, relative to the normotensive condition. This
increase in flow resistance is essential in maintaining the myocardial perfusion despite the
increase in aortic pressure. The study also discussed the effects of HPN on coronary flow
prior to remodeling. Hypertension in the absence of coronary arterial remodeling resulted
in substantial and adverse effects on coronary flow, shown by the 13- and 47-fold increase
in the LCA and RCA flow rate, respectively, vs the HPN condition with remodeling.
Therefore, this study demonstrated the effect of HPN on coronary flow resistance and
discussed the important role played by remodeling in the coronary circulation under
hypertension.
What impact does hypertension have on left ventricular function?
This study evidenced the substantial impact of HPN on LV function by characterizing
the ventricular workload. In specific aim 3, stroke work, calculated from the P-V chart,
was assessed and compared under normotensive, PreHTN and HPN conditions. The results
revealed ventricular overloads in the PreHTN and HPN conditions, characterized by the
21% and 50% increase in stroke work, respectively, relative to the normotensive condition.
These findings suggest a strong association between HPN and LV hypertrophy.
In conclusion, this thesis demonstrated that HPN contributes to alterations in coronary
flow resistance, ventricular overload and WSS abnormalities on the AV leaflets. These
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WSS abnormalities might lead to CAVD pathogenesis, which requires further analysis and
validation. However, results from this study provide important insights on the association
between HPN and CAVD and compelling support to the hemodynamic etiology linking
the two diseases.
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CHAPTER 7:
LIMITATIONS

3D FSI valve models were developed and were able to simulate blood flow under
normotensive, PreHTN and HPN conditions. These models predicted the existence of
abnormal hemodynamics, alterations in WSS environment and increased leaflet
deformation, increased coronary resistance and ventricular overloads in the PreHTN and
HPN case. However, this goal was achieved by making simplifications to the model and
the methodology. These limitations have already been extensively discussed in specific
aim 1. The present chapter revisits those limitations in a summarized manner as follows:


the valvular geometry consisted of identical, equiangularly spaced leaflets and
sinus unlike the realistic aortic root



Secondly, the leaflet material was approximated as isotropic and homogenous
instead of accounting for the anisotropy in the leaflets due to the fiber orientation



Blood flow was modeled as laminar although the flow is transitional at peak systole



The adopted ALE method generated a gap between the leaflets leading to
regurgitation during diastole

In conclusion, the models had certain limitations which were thoroughly discussed and
could be vastly improved in future studies by adopting new methods and modeling
approach.
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